The comparison of parathyroid hormone degradation effect by various protease inhibitors in blood specimen;Korean Source

Korean Journal of Laboratory Medicine

Volumn 29, Issue 2, 2009, Pages 104-109

  Kim, Yeong Sic ^a   Kwon, Hi Jeong ^a   Lee, Hae Kyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Metal ion; Parathyroid hormone; Serine proteases

Indexed keywords

APROTININ; DRUG DERIVATIVE; EDETIC ACID; LEUCINE; LEUPEPTIN; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PARATHYROID HORMONE; PROTEINASE INHIBITOR;

ARTICLE; BLOOD; BLOOD SAMPLING; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METABOLISM; TIME;

APROTININ; BLOOD SPECIMEN COLLECTION; EDETIC ACID; FEMALE; HUMANS; LEUCINE; LEUPEPTINS; MALE; PARATHYROID HORMONE; PROTEASE INHIBITORS; TIME FACTORS;

EID: 67249135220     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2009.29.2.104     Document Type: Article

References (15)

1. Endres DB and Rude RK. Mineral and bone metabolism. In: Burtis CA, Ashwood ER, et al. eds. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. Philadelphia: Elsevier Saunders, 2006:1891-965.
2. Juppner H, Gardella TJ, et al. Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development. In: DeGroot LJ, Jameson JL, et al. eds. Endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2006:1377-417.
3. Levin GE and Nisbet JA. Stability of parathyroid hormone-related protein and parathyroid hormone at room temperature. Ann Clin Biochem 1994;31:497-500.
4. Russell D and Henley R. The stability of parathyroid hormone in blood and serum samples at 4 degrees C and at room temperature. Ann Clin Biochem 1995;32:216-7.
5. Evans MJ, Livesey JH, Ellis MJ, Yandle TG. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem 2001;34:107-12.
6. Gerhartz B, Niestroj AJ, et al. Enzyme classes and mechanisms. In: Smith HJ and Simon C, eds. Proteinase and peptidase inhibition: recent potential targets for drug development. London and New York: Taylor and Francis, 2002:1-20.
7. Garcia-Touchard A, Henry TD, Sangiorgi G, Spagnoli LG, Mauriello A, Conover C, et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 2005;25:1119-27.
8. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 2003;4:544-58.
9. Teal TK, Reed M, Stevens PE, Lamb EJ. Stability of parathyroid hormone ex vivo in haemodialysis patients. Ann Clin Biochem 2003; 40:191-3.
10. National Committee for Clinical Laboratory Standards. Tubes and additives for venous blood specimen collection; approved standard, H1-A5. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003.
11. Auld DS. Removal and replacement of metal ions in metallopeptidases. In: Barrett AJ, ed. Proteolytic enzymes: aspartic and metallopeptidases. San Diego: Academic Press, 1995:228-42.
12. Anderson NR, Nicholas J, Holland MR, Gama R. Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone. Ann Clin Biochem 2003;40:188-90.
13. English E, McFarlane I, Taylor KP, Halsall DJ. The effect of potassium EDTA on the stability of parathyroid hormone in whole blood. Ann Clin Biochem 2007;44:297-9.
14. Chi CW, Liu HZ, Liu CY, Chibber BA, Castellino FJ. The inhibition of the enzymic activity of blood coagulation and fibrinolytic serine proteases by a new leupeptin-like inhibitor, and its structural analogues, isolated from Streptomyces griseus. J Antibiot 1989;42: 1506-12.
15. Rao GH, White JG, Cox CA. Influence a calcium dependent protease inhibitor on platelet activation and secretion. Thromb Res 1987;47: 625-37.